Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Only possible way out now is long-haulers. Otherwise, it's dilution city.
Safe yes, it's proven in their trials. Has zero side effects. Don't need FDA to tell me how to read trials results. If the FDA told you jumping off a bridge was safe and effective, would you believe them? They don't dictate truth. They dictate money. Having said that, money is why I invest and the FDA is refusing to give any to CYDY. That's all any investor needs to know. Right now it's a battle. Will Leronlimab get it's deserved approval for HIV? Probably not. The FDA changed the requirements in order to reject Leronlimab. It's all there clear as day. FDA approves another drug, then changes the rules and rejects Leronlimab which had statistical significant results. Look it up. It's all there.
I also found it interesting why he was reinstated. Why now? Why not a couple years ago?
From what I've researched about mRNA tech, it was ahead of its time back in 2015 when Dr Koos, Dr Helen S., and several others were working together at RGBP. Unfortunately they were too ahead of the times with their mRNA tech. Nobody willing to fund it.
Enter COVID-19 and Pfizer. Pfizer's mRNA vaccine brought a lot more value to mRNA tech. It's the hot new toy on the play ground and everybody wants it.
So why was Dr. Koos reinstated now? The answer seems obvious. Their mRNA tech was costing them money and wasn't going anywhere, but times have changed. mRNA technology is the future and treating cancer is the holy grail. He was reinstated to bring the company back current in order to sell it. The new patent solidified their hold on it. Now it's a matter of when the RM/BO happens.
I'm not following.
RM? Doesn't that stand for Reverse Merge?
Clear manipulation today. Calculated large blocks. They pushed it down as far as retail would sell. Looking like bottom between 65-72 right now. Thought that same thing at 8 though, lol.
Big time buys compared to last 30 days. Filings are coming unless vitx wants to be delisted.
Keep an eye out for bottom. Could this be it?
But OS hasn't changed.
Filings coming in a couple weeks.
Digital dividends, merger with sig_alt5 and short squeeze coming. Buy and hold. We got them.
More news coming any day. Filings/pink current. Then we'll see what Koos has been up to with his patents. Likely a RM or BO.
Wow. Gapping to 0250 now.
Cancer vaccine. Patent obtained. What's next? Pink then RM/BO
Chart stayed above .022 previous resistance. Bullish.
My guess why he sold $50,000 worth of ONPH shares was to pay for the patent and financial audits.
Didn't get to average down today with my buy order at .0142.
I'm not upset :)
Know what you own. Dr Koos CEO of Regen received 50,000 shares of ONPH. Just ask yourself why ONPH gave them those shares. I'll give you a hint...mRNA tech is the future.
Big loading between 50-52
Nice pop. Let's keep it going.
Spreads getting larger.
$PBYA one exam prep trades course helped over 50,000 students. Price ranges between $800 - $2300 per student.
Now today's news. A 500% increase in students year-over-year.
They are growing both companies: NCAP and one exam prep. Both companies complement eachother.
Tesla NCAP contract translates into more students for one exam.
You don't think they'll market one exam prep courses to potential students during their 10 month training program at Tesla, marathon, and Bea systems?
Of course they will. They'll also market their training programs to students taking their online courses.
This company is at ground level. They just got out of their reorganization to reduce expenses.
Twitter account launching soon.
Yes. Check out their website. They address going and staying current. The company is moving in the right direction.
Here comes ETRF to scare people out if shares.
Just low volume dumping. Feel bad for whoever lost their many.
Nice support. Could've been worse. See y'all tomorrow. Squeeze incoming.
Wrong chat, dude.
The training is taking place ONSITE. It's states clearly in the PR.
That means PBYA is sending trainers to the InSite locations.
Low volume. Investors holding. Not much selling. We're in a waiting period. Filings coming. Pink current. Then.merger/buyout.
Almost 300M volume in first 30 minutes of trading.
They plan to go pink current. Filings imminent.
COVID-19 put PBYA in a highly profitable situation. Lots of traders need recertification, and they are one of the few that can offer training and recertification for crane operators and many more trades.
Why do you think $tsla $mro and $basey hired them?
MORE COMING!
$pbya catalysts
- $TSLA, $MRO, $BASEY contract details
- Additional fortune 500 company contracts coming
- Filings / pink current
- New website launch
Tesla feed posted news about contract.
PBYA / NACB
ProBility wholly owns NCAB
? PBYA the First nationwide test prep, training, and education for vocational trades
“Through its divisions One Exam Prep, LLC,
North American Crane Bureau Group Inc and Disco Learning Media Inc, ProBility is aiming to become the first nationwide company addressing test prep, training, and education for vocational trades.”
ProBility Media Provides Corporate Update
“In response to the Company’s unfortunate turn of events and during the summer of 2018, Management began a restructuring and cost-cutting program for the purpose of generating a profit. This program led the Company to aggressive reductions in operating expenses and the restructure of its debt.”
Now we know why they were in triple digits a couple months ago.
? It’s not a problem any more. See below.
“During the first quarter of 2019, the Company worked to reduce overhead expenses by:
1. electing to become an “alternative reporting” company;
2. Consolidating its business into three companies, North American Crane Bureau, One Exam Prep and Disco Learning Media.
3. Eliminating non-profitable assets.
Through the efforts of the reorganization, the Company’s revenue and operating expenses both decreased, however expenses decreased at a rate such that the Company’s operating loss for 2020 was minimal.”
No company is blamed for 2020 financial losses. COVID hit everyone hard, yet they reorganized and saved their 2020 financials. IMPRESSIVE!
The result of their reorganization is three wholly owned subsidiary companies:
North American Crane Bureau https://www.cranesafe.com/ ;
Learn more about what they do here:
Converted the DD to twitter.
$PBYA / NCAP DDhttps://t.co/tFJcIinOvf
— Mambo Trading (@MamboTrading) June 29, 2021
Spread it around if you're in this play.@AlexDelarge6553
Boooom! You got it! Shorts are scrambling. You could see it all day. Elon Musk HATES shorts. PBYA news under Tesla news feed. Very curious.
Ameritrade news feed under Tesla showing the PR about the contract. It's as real as it gets.
This is huge news. Also under the contract MRO and BESAY!
Anything under 5c is a steal. This contract is going to create a huge revenue stream.
It's certainly setting up for a multi day run with this volume. Major accumulation right now.
2B volume and still 2hours left to trade. HOLY S***!!!
I posted in the discussion forum. Let's see what happens.